These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials. Edwards MS; Levin VA; Wilson CB Cancer Treat Rep; 1980; 64(12):1179-205. PubMed ID: 7008937 [TBL] [Abstract][Full Text] [Related]
45. [A new path for research in childhood cancer: high-dose chemotherapy with bone-marrow autograft]. Lemerle J; Hartmann O Soins Gynecol Obstet Pueric Pediatr; 1984; (39-40):66. PubMed ID: 6393405 [No Abstract] [Full Text] [Related]
46. [Perfusion treatment of extremities in malignant melanoma. 9 year experience in 134 patients]. Nachbur B; von Wattenwyl G; Goldhirsch A Helv Chir Acta; 1983 Jan; 49(5):629-32. PubMed ID: 6832996 [No Abstract] [Full Text] [Related]
47. [Chemotherapy of malignant tumors by arterial approach]. Escó Barón R Rev Med Univ Navarra; 1983 Mar; 27(1):9-20. PubMed ID: 6669836 [No Abstract] [Full Text] [Related]
48. Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001). Blaney SM; Boyett J; Friedman H; Gajjar A; Geyer R; Horowtiz M; Hunt D; Kieran M; Kun L; Packer R; Phillips P; Pollack IF; Prados M; Heideman R J Clin Oncol; 2005 Jan; 23(3):525-31. PubMed ID: 15659498 [TBL] [Abstract][Full Text] [Related]
49. Phase I-II diaziquone chemotherapy in brain tumors. Madajewicz S; Spaulding M; Bhimani S; Avellanosa A; DeLos Santos R; Perry A; Zeigler P; Kirshner J Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706 [No Abstract] [Full Text] [Related]
50. [High-dose chemotherapy with autologous bone marrow rescue for malignant brain tumors (author's transl)]. Kuwamura K; Kokunai T; Kanazawa Y; Yamada T Neurol Med Chir (Tokyo); 1982 May; 22(5):353-9. PubMed ID: 6180336 [No Abstract] [Full Text] [Related]
51. Newer treatment options for patients in first relapse. From the Multiple Myeloma Research Foundation. Richardson P Oncology (Williston Park); 2006 May; 20(6):633-8. PubMed ID: 16773847 [No Abstract] [Full Text] [Related]
53. [Massive chemotherapy and bone marrow autografts in solid tumors and non-leukemic lymphomas in pediatrics]. Philip T; Bouffet E; Biron P; Philip I; Brunat-Mentigny M Ann Pediatr (Paris); 1984 Oct; 31(9):745-52. PubMed ID: 6395777 [No Abstract] [Full Text] [Related]
57. Current legal intervention regarding "experimental" treatments must be changed: an analysis of high doses of chemotherapy with autologous bone marrow transplantation for breast cancer patients. Smayda E J Law Health; 1998-1999; 13(2):257-80. PubMed ID: 10947396 [No Abstract] [Full Text] [Related]
58. [Means of increasing the effectiveness of drug therapy of malignant neoplasms]. Borisov VI; Rusakov IG; Bogdanova NV Sov Med; 1986; (6):53-8. PubMed ID: 3529449 [No Abstract] [Full Text] [Related]
59. Regional cancer chemotherapy. Westbury G Br J Surg; 1967 Oct; 54(10):824-7. PubMed ID: 6072197 [No Abstract] [Full Text] [Related]
60. [TREATMENTS OF LEUKOPENIA ASSOCIATED WITH THE THERAPY OF MALIGNANT TUMORS]. KUBOTA J Fukuoka Igaku Zasshi; 1963 Jun; 54():627-39. PubMed ID: 14070411 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]